Clin Epidemiol 16:30718 Rasmussen L, Andersen JH, Karlstad , Giunta DH, Linder M, Furu K et al (2024) Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: a register-based drug utilization study
As a preventive cardiologist, I want all patients with heart conditions and their primary care doctors to understand why this development is causing so much excitement and what it might mean for treating and preventing cardiovascular conditions
Estas son algunas tendencias y desarrollos clave a tener en cuenta: Agonistas del Receptor GLP-1 de Nueva Generacin Las compaas farmacuticas estn desarrollando activamente agonistas del receptor GLP-1 de nueva generacin con perfiles de eficacia y seguridad mejorados
Unlike other peptides, Ipamorelin is known for its selective action, minimizing the release of cortisol and other stress hormones, making it a popular choice among athletes and fitness enthusiasts
Modern soft tissue pathology: tumors and non-neoplastic conditions (Cambridge Medicine)
